Tag: cell lysis and fractionation market growth

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Cell Lysis And Fractionation Market Growth Analysis: How Will Revenue Expand During The Forecast Period?

The market for cell lysis and fractionation technologies experienced robust expansion recently, projected to climb from $3.69 billion in 2025 to $3.95 billion in 2026, reflecting a compound annual growth rate of 7.0%. This upward trend over the past period is linked to heightened engagement in molecular biology investigations, an increase in proteomics research, broader adoption of nucleic acid purification methods, the proliferation of life science research facilities, and a greater need for consistent sample preparation processes.

The market for cell lysis and fractionation is poised for significant expansion, projected to reach $5.16 billion by 2030, reflecting a compound annual growth rate of 6.9%. This anticipated growth stems from several key drivers, including escalating investments in proteomics and genomics research, a greater embrace of automated sample preparation techniques, a heightened emphasis on high-throughput analysis, the broadening scope of biopharmaceutical research endeavors, and the increasing integration of laboratory systems. Furthermore, prominent trends shaping this market during the forecast period involve a rising preference for automated cell lysis systems, a burgeoning demand for highly effective protein extraction methods, the expanding utilization of both chemical and mechanical lysis approaches, an increase in fractionation-based sample preparation strategies, and a reinforced commitment to preserving sample integrity.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14064&type=smp

Cell Lysis And Fractionation Market Opportunity Drivers: What Is Creating New Revenue Potential?

The increasing emphasis on personalized medicine is anticipated to significantly boost the cell lysis and fractionation sectors. This innovative medical approach leverages an individual’s genetic blueprint for disease diagnosis and therapeutic management, essentially customizing medical plans and interventions based on each patient’s distinct characteristics, particularly their genetic makeup. Cell lysis and fractionation are instrumental in this precision medicine paradigm, enabling the isolation and examination of specific subcellular components from patient specimens like proteins, organelles, and nucleic acids. Consequently, researchers and healthcare providers can delve into the molecular mechanisms underlying ailments and devise tailored treatments aligned with each patient’s unique molecular profile. A notable indicator of this trend, as reported in February 2024 by the Personalized Medicine Coalition, a US non-profit, is the FDA’s approval of 7 new personalized cancer treatments in 2023, contributing to a total of 26 personalized therapies, a substantial rise from the 12 approvals seen in 2022. Thus, the heightened focus on personalized medicine directly fuels the expansion of the cell lysis and fractionation markets.

An escalating need within the biopharmaceutical sector is poised to stimulate expansion in the cell lysis and fractionation market. This industry, dedicated to the creation, manufacture, and marketing of medications and treatments derived from biological sources through biotechnology, is experiencing robust growth. This expansion is largely attributed to the increasing incidence of chronic and intricate diseases, which in turn fuels the demand for sophisticated, targeted therapeutics. Cell lysis and fractionation are vital to the biopharmaceutical industry’s operations, facilitating the disruption of cells to liberate and isolate crucial intracellular biomolecules, including proteins, enzymes, and nucleic acids, which are indispensable for the development of drugs, the production of biologics, and ongoing research endeavors. For illustration, IQVIA, a US-based entity offering biopharmaceutical development services, projected in January 2024 that global spending on biotechnology is slated to surpass $892 billion by the year 2028. Consequently, the amplified requirements from the biopharmaceutical industry are serving as a key driver for the growth of the cell lysis and fractionation market.

Cell Lysis And Fractionation Market Segment Analysis Highlighting Growth Areas

The cell lysis and fractionation market covered in this report is segmented –

1) By Type: Mammalian Cells, Microbial Cells

2) By Application: Nucleic Acid Purification And Isolation, Protein Purification And Isolation

3) By End-User: Research Laboratories And Institutes, Biopharmaceutical, Biotechnology Companies

Subsegments:

1) By Mammalian Cells: Adherent Mammalian Cells, Suspension Mammalian Cells, Primary Cells, Cell Lines

2) By Microbial Cells: Bacterial Cells, Yeast Cells, Fungal Cells, Algal Cells

Cell Lysis And Fractionation Market Innovation Trends Driving Future Development

Key players within the cell lysis and fractionation sector are concentrating their efforts on the development and dissemination of innovative offerings, including specialized lysis kits for cell and gene therapies (CGT) that leverage viral vectors, as a strategic maneuver to bolster their market standing. This advanced lysis kit technology streamlines the process of lysing Adeno-associated virus (AAV), thereby enhancing standard operating procedures, fortifying quality assurance measures, and elevating safety standards, all while promoting uniformity in bioprocessing operations. To illustrate this point, QIAGEN, a prominent German entity specializing in sample and assay technologies, introduced its new CGT Viral Vector Lysis Kit in July 2023. This product facilitates the precise and consistent determination of viral titers across various serotypes, commencing with the cellular lysate. This newly released CGT viral vector lysis kit serves as a valuable addition to QIAGEN’s continuously growing suite of digital PCR solutions tailored for the biopharmaceutical industry, which already encompasses three QIAcuity Residual DNA Quantification Kits designed to detect residual host cell DNA contamination and ten QIAcuity Cell and Gene Therapy (CGT) dPCR Assays aimed at quantifying Adeno-associated virus (AAV) titers.

Cell Lysis And Fractionation Market Leading Companies: Who Holds Significant Market Presence?

Major companies operating in the cell lysis and fractionation market are Hoffmann-La Roche Ltd, Merck & Co. Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Lonza Group AG, Illumina Inc., Beckman Coulter Inc., PerkinElmer Inc., IDEX Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Eppendorf AG, Miltenyi Biotec B.V. & Co. KG, Promega Corporation, Takara Bio Inc., Abcam plc, Cell Signaling Technology Inc., BioVision Inc., Diagenode LLC, Claremont BioSolutions LLC, Norgen Biotek Corp., Qsonica LLC, Labfreez Instruments Group Co. Ltd.

Access The Complete Cell Lysis And Fractionation Market Report:

https://www.thebusinessresearchcompany.com/report/cell-lysis-and-fractionation-global-market-report

Cell Lysis And Fractionation Market Largest Region By Revenue And Market Share

North Americawas the largest region in the cell lysis and fractionation market in 2025. The regions covered in the cell lysis and fractionation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Cell Lysis And Fractionation Market Growth Analysis: How Will Revenue Expand During The Forecast Period?

The market for cell lysis and fractionation technologies experienced robust expansion recently, projected to climb from $3.69 billion in 2025 to $3.95 billion in 2026, reflecting a compound annual growth rate of 7.0%. This upward trend over the past period is linked to heightened engagement in molecular biology investigations, an increase in proteomics research, broader adoption of nucleic acid purification methods, the proliferation of life science research facilities, and a greater need for consistent sample preparation processes.

The market for cell lysis and fractionation is poised for significant expansion, projected to reach $5.16 billion by 2030, reflecting a compound annual growth rate of 6.9%. This anticipated growth stems from several key drivers, including escalating investments in proteomics and genomics research, a greater embrace of automated sample preparation techniques, a heightened emphasis on high-throughput analysis, the broadening scope of biopharmaceutical research endeavors, and the increasing integration of laboratory systems. Furthermore, prominent trends shaping this market during the forecast period involve a rising preference for automated cell lysis systems, a burgeoning demand for highly effective protein extraction methods, the expanding utilization of both chemical and mechanical lysis approaches, an increase in fractionation-based sample preparation strategies, and a reinforced commitment to preserving sample integrity.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14064&type=smp

Cell Lysis And Fractionation Market Opportunity Drivers: What Is Creating New Revenue Potential?

The increasing emphasis on personalized medicine is anticipated to significantly boost the cell lysis and fractionation sectors. This innovative medical approach leverages an individual’s genetic blueprint for disease diagnosis and therapeutic management, essentially customizing medical plans and interventions based on each patient’s distinct characteristics, particularly their genetic makeup. Cell lysis and fractionation are instrumental in this precision medicine paradigm, enabling the isolation and examination of specific subcellular components from patient specimens like proteins, organelles, and nucleic acids. Consequently, researchers and healthcare providers can delve into the molecular mechanisms underlying ailments and devise tailored treatments aligned with each patient’s unique molecular profile. A notable indicator of this trend, as reported in February 2024 by the Personalized Medicine Coalition, a US non-profit, is the FDA’s approval of 7 new personalized cancer treatments in 2023, contributing to a total of 26 personalized therapies, a substantial rise from the 12 approvals seen in 2022. Thus, the heightened focus on personalized medicine directly fuels the expansion of the cell lysis and fractionation markets.

An escalating need within the biopharmaceutical sector is poised to stimulate expansion in the cell lysis and fractionation market. This industry, dedicated to the creation, manufacture, and marketing of medications and treatments derived from biological sources through biotechnology, is experiencing robust growth. This expansion is largely attributed to the increasing incidence of chronic and intricate diseases, which in turn fuels the demand for sophisticated, targeted therapeutics. Cell lysis and fractionation are vital to the biopharmaceutical industry’s operations, facilitating the disruption of cells to liberate and isolate crucial intracellular biomolecules, including proteins, enzymes, and nucleic acids, which are indispensable for the development of drugs, the production of biologics, and ongoing research endeavors. For illustration, IQVIA, a US-based entity offering biopharmaceutical development services, projected in January 2024 that global spending on biotechnology is slated to surpass $892 billion by the year 2028. Consequently, the amplified requirements from the biopharmaceutical industry are serving as a key driver for the growth of the cell lysis and fractionation market.

Cell Lysis And Fractionation Market Segment Analysis Highlighting Growth Areas

The cell lysis and fractionation market covered in this report is segmented –

1) By Type: Mammalian Cells, Microbial Cells

2) By Application: Nucleic Acid Purification And Isolation, Protein Purification And Isolation

3) By End-User: Research Laboratories And Institutes, Biopharmaceutical, Biotechnology Companies

Subsegments:

1) By Mammalian Cells: Adherent Mammalian Cells, Suspension Mammalian Cells, Primary Cells, Cell Lines

2) By Microbial Cells: Bacterial Cells, Yeast Cells, Fungal Cells, Algal Cells

Cell Lysis And Fractionation Market Innovation Trends Driving Future Development

Key players within the cell lysis and fractionation sector are concentrating their efforts on the development and dissemination of innovative offerings, including specialized lysis kits for cell and gene therapies (CGT) that leverage viral vectors, as a strategic maneuver to bolster their market standing. This advanced lysis kit technology streamlines the process of lysing Adeno-associated virus (AAV), thereby enhancing standard operating procedures, fortifying quality assurance measures, and elevating safety standards, all while promoting uniformity in bioprocessing operations. To illustrate this point, QIAGEN, a prominent German entity specializing in sample and assay technologies, introduced its new CGT Viral Vector Lysis Kit in July 2023. This product facilitates the precise and consistent determination of viral titers across various serotypes, commencing with the cellular lysate. This newly released CGT viral vector lysis kit serves as a valuable addition to QIAGEN’s continuously growing suite of digital PCR solutions tailored for the biopharmaceutical industry, which already encompasses three QIAcuity Residual DNA Quantification Kits designed to detect residual host cell DNA contamination and ten QIAcuity Cell and Gene Therapy (CGT) dPCR Assays aimed at quantifying Adeno-associated virus (AAV) titers.

Cell Lysis And Fractionation Market Leading Companies: Who Holds Significant Market Presence?

Major companies operating in the cell lysis and fractionation market are Hoffmann-La Roche Ltd, Merck & Co. Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Lonza Group AG, Illumina Inc., Beckman Coulter Inc., PerkinElmer Inc., IDEX Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Eppendorf AG, Miltenyi Biotec B.V. & Co. KG, Promega Corporation, Takara Bio Inc., Abcam plc, Cell Signaling Technology Inc., BioVision Inc., Diagenode LLC, Claremont BioSolutions LLC, Norgen Biotek Corp., Qsonica LLC, Labfreez Instruments Group Co. Ltd.

Access The Complete Cell Lysis And Fractionation Market Report:

https://www.thebusinessresearchcompany.com/report/cell-lysis-and-fractionation-global-market-report

Cell Lysis And Fractionation Market Largest Region By Revenue And Market Share

North Americawas the largest region in the cell lysis and fractionation market in 2025. The regions covered in the cell lysis and fractionation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Cell Lysis And Fractionation Market Growth Analysis: How Will Revenue Expand During The Forecast Period?

The market for cell lysis and fractionation technologies experienced robust expansion recently, projected to climb from $3.69 billion in 2025 to $3.95 billion in 2026, reflecting a compound annual growth rate of 7.0%. This upward trend over the past period is linked to heightened engagement in molecular biology investigations, an increase in proteomics research, broader adoption of nucleic acid purification methods, the proliferation of life science research facilities, and a greater need for consistent sample preparation processes.

The market for cell lysis and fractionation is poised for significant expansion, projected to reach $5.16 billion by 2030, reflecting a compound annual growth rate of 6.9%. This anticipated growth stems from several key drivers, including escalating investments in proteomics and genomics research, a greater embrace of automated sample preparation techniques, a heightened emphasis on high-throughput analysis, the broadening scope of biopharmaceutical research endeavors, and the increasing integration of laboratory systems. Furthermore, prominent trends shaping this market during the forecast period involve a rising preference for automated cell lysis systems, a burgeoning demand for highly effective protein extraction methods, the expanding utilization of both chemical and mechanical lysis approaches, an increase in fractionation-based sample preparation strategies, and a reinforced commitment to preserving sample integrity.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14064&type=smp

Cell Lysis And Fractionation Market Opportunity Drivers: What Is Creating New Revenue Potential?

The increasing emphasis on personalized medicine is anticipated to significantly boost the cell lysis and fractionation sectors. This innovative medical approach leverages an individual’s genetic blueprint for disease diagnosis and therapeutic management, essentially customizing medical plans and interventions based on each patient’s distinct characteristics, particularly their genetic makeup. Cell lysis and fractionation are instrumental in this precision medicine paradigm, enabling the isolation and examination of specific subcellular components from patient specimens like proteins, organelles, and nucleic acids. Consequently, researchers and healthcare providers can delve into the molecular mechanisms underlying ailments and devise tailored treatments aligned with each patient’s unique molecular profile. A notable indicator of this trend, as reported in February 2024 by the Personalized Medicine Coalition, a US non-profit, is the FDA’s approval of 7 new personalized cancer treatments in 2023, contributing to a total of 26 personalized therapies, a substantial rise from the 12 approvals seen in 2022. Thus, the heightened focus on personalized medicine directly fuels the expansion of the cell lysis and fractionation markets.

An escalating need within the biopharmaceutical sector is poised to stimulate expansion in the cell lysis and fractionation market. This industry, dedicated to the creation, manufacture, and marketing of medications and treatments derived from biological sources through biotechnology, is experiencing robust growth. This expansion is largely attributed to the increasing incidence of chronic and intricate diseases, which in turn fuels the demand for sophisticated, targeted therapeutics. Cell lysis and fractionation are vital to the biopharmaceutical industry’s operations, facilitating the disruption of cells to liberate and isolate crucial intracellular biomolecules, including proteins, enzymes, and nucleic acids, which are indispensable for the development of drugs, the production of biologics, and ongoing research endeavors. For illustration, IQVIA, a US-based entity offering biopharmaceutical development services, projected in January 2024 that global spending on biotechnology is slated to surpass $892 billion by the year 2028. Consequently, the amplified requirements from the biopharmaceutical industry are serving as a key driver for the growth of the cell lysis and fractionation market.

Cell Lysis And Fractionation Market Segment Analysis Highlighting Growth Areas

The cell lysis and fractionation market covered in this report is segmented –

1) By Type: Mammalian Cells, Microbial Cells

2) By Application: Nucleic Acid Purification And Isolation, Protein Purification And Isolation

3) By End-User: Research Laboratories And Institutes, Biopharmaceutical, Biotechnology Companies

Subsegments:

1) By Mammalian Cells: Adherent Mammalian Cells, Suspension Mammalian Cells, Primary Cells, Cell Lines

2) By Microbial Cells: Bacterial Cells, Yeast Cells, Fungal Cells, Algal Cells

Cell Lysis And Fractionation Market Innovation Trends Driving Future Development

Key players within the cell lysis and fractionation sector are concentrating their efforts on the development and dissemination of innovative offerings, including specialized lysis kits for cell and gene therapies (CGT) that leverage viral vectors, as a strategic maneuver to bolster their market standing. This advanced lysis kit technology streamlines the process of lysing Adeno-associated virus (AAV), thereby enhancing standard operating procedures, fortifying quality assurance measures, and elevating safety standards, all while promoting uniformity in bioprocessing operations. To illustrate this point, QIAGEN, a prominent German entity specializing in sample and assay technologies, introduced its new CGT Viral Vector Lysis Kit in July 2023. This product facilitates the precise and consistent determination of viral titers across various serotypes, commencing with the cellular lysate. This newly released CGT viral vector lysis kit serves as a valuable addition to QIAGEN’s continuously growing suite of digital PCR solutions tailored for the biopharmaceutical industry, which already encompasses three QIAcuity Residual DNA Quantification Kits designed to detect residual host cell DNA contamination and ten QIAcuity Cell and Gene Therapy (CGT) dPCR Assays aimed at quantifying Adeno-associated virus (AAV) titers.

Cell Lysis And Fractionation Market Leading Companies: Who Holds Significant Market Presence?

Major companies operating in the cell lysis and fractionation market are Hoffmann-La Roche Ltd, Merck & Co. Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Lonza Group AG, Illumina Inc., Beckman Coulter Inc., PerkinElmer Inc., IDEX Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Eppendorf AG, Miltenyi Biotec B.V. & Co. KG, Promega Corporation, Takara Bio Inc., Abcam plc, Cell Signaling Technology Inc., BioVision Inc., Diagenode LLC, Claremont BioSolutions LLC, Norgen Biotek Corp., Qsonica LLC, Labfreez Instruments Group Co. Ltd.

Access The Complete Cell Lysis And Fractionation Market Report:

https://www.thebusinessresearchcompany.com/report/cell-lysis-and-fractionation-global-market-report

Cell Lysis And Fractionation Market Largest Region By Revenue And Market Share

North Americawas the largest region in the cell lysis and fractionation market in 2025. The regions covered in the cell lysis and fractionation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Cell Lysis And Fractionation Market Projected To Reach By 2030?

The cell lysis and fractionation market has shown robust growth recently. This market is projected to expand from $3.69 billion in 2025 to $3.95 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.0%. Historically, this growth has stemmed from factors such as heightened molecular biology research, a rise in proteomics investigations, the increasing adoption of nucleic acid purification methods, the proliferation of life science laboratories, and a greater need for standardized sample preparation.

The cell lysis and fractionation market is anticipated to experience substantial growth over the coming years. By 2030, its size is projected to reach $5.16 billion, expanding at a compound annual growth rate (CAGR) of 6.9%. This projected growth during the forecast period is largely driven by factors such as greater investments in proteomics and genomics studies, a broader uptake of automated sample preparation techniques, an intensified focus on high-throughput analysis, the expansion of biopharmaceutical research pipelines, and an increased implementation of integrated laboratory systems. Key trends anticipated within this period involve the increasing integration of automated cell lysis systems, a surging demand for highly efficient protein extraction, the expanding application of both chemical and mechanical lysis methods, the broadening scope of fractionation-based sample preparation, and an elevated emphasis on maintaining sample integrity.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/cell-lysis-and-fractionation-global-market-report

Which Important Drivers Are Guiding The Cell Lysis And Fractionation Market Growth?

The increasing emphasis on personalized medicine is anticipated to fuel the expansion of the cell lysis and fractionation markets in the future. This innovative medical approach utilizes an individual’s genetic blueprint for disease diagnosis and treatment, customizing medical strategies and therapies based on each patient’s distinct genetic characteristics. Cell lysis and fractionation are vital for precision medicine, enabling the isolation and examination of specific subcellular components—like proteins, organelles, and nucleic acids—from patient samples. This capability empowers scientists and healthcare providers to explore the molecular underpinnings of diseases and develop bespoke treatments tailored to each patient’s distinct molecular profile. For example, data from February 2024, provided by the US-based nonprofit Personalized Medicine Coalition (PMC), indicates that in 2023, the Food and Drug Administration (FDA) sanctioned 7 new personalized cancer treatments, contributing to a total of 26 personalized treatments approved that year, which represents a notable rise compared to the 12 approvals in 2022. Consequently, this heightened attention on personalized medicine is stimulating the expansion of the cell lysis and fractionation markets.

Which Segment Categories Are Included In The Cell Lysis And Fractionation Market Segment Analysis?

The cell lysis and fractionation market covered in this report is segmented –

1) By Type: Mammalian Cells, Microbial Cells

2) By Application: Nucleic Acid Purification And Isolation, Protein Purification And Isolation

3) By End-User: Research Laboratories And Institutes, Biopharmaceutical, Biotechnology Companies

Subsegments:

1) By Mammalian Cells: Adherent Mammalian Cells, Suspension Mammalian Cells, Primary Cells, Cell Lines

2) By Microbial Cells: Bacterial Cells, Yeast Cells, Fungal Cells, Algal Cells

What Trends Are Influencing The Evolution Of The Cell Lysis And Fractionation Market?

Leading companies in the cell lysis and fractionation market are concentrating on introducing advanced solutions, such as CGT (cell and gene therapy) viral vector lysis kits, to gain a competitive advantage. These lysis kits provide a simplified AAV (Adeno-associated virus) lysis methodology aimed at improving SOPs (Standard Operating Procedures), quality control, and safety, while also standardizing bioprocessing workflows. For example, in July 2023, QIAGEN, a Germany-based supplier of sample and assay technologies, launched its new CGT Viral Vector Lysis Kit. This innovation allows for the quantification of virus titers for several serotypes using an exact and uniform procedure that begins with cell lysates. This new CGT viral vector lysis kit enhances QIAGEN’s rapidly expanding digital PCR portfolio for the biopharma industry, which already includes three QIAcuity Residual DNA Quantification Kits to monitor host cell DNA carryover and ten QIAcuity Cell and Gene Therapy (CGT) dPCR Assays for use in adeno-associated virus (AAV) titer quantification.

Who Are The Active Companies Shaping The Cell Lysis And Fractionation Market?

Major companies operating in the cell lysis and fractionation market are Hoffmann-La Roche Ltd, Merck & Co. Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Lonza Group AG, Illumina Inc., Beckman Coulter Inc., PerkinElmer Inc., IDEX Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Eppendorf AG, Miltenyi Biotec B.V. & Co. KG, Promega Corporation, Takara Bio Inc., Abcam plc, Cell Signaling Technology Inc., BioVision Inc., Diagenode LLC, Claremont BioSolutions LLC, Norgen Biotek Corp., Qsonica LLC, Labfreez Instruments Group Co. Ltd.

Get The Full Cell Lysis And Fractionation Market Report:

https://www.thebusinessresearchcompany.com/report/cell-lysis-and-fractionation-global-market-report

Which Region Is The Top Contributor To The Cell Lysis And Fractionation Market By Share?

North America was the largest region in the cell lysis and fractionation market in 2025. The regions covered in the cell lysis and fractionation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Cell Lysis And Fractionation Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/cell-lysis-and-fractionation-global-market-report

Browse Through More Reports Similar to the Global Cell Lysis And Fractionation Market 2026, By The Business Research Company

Cell Expansion Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-expansion-global-market-report

Plasma Fractionation Market Report 2026

https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

Cell Separation Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-separation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Cell Lysis And Fractionation Market During 2026–2030?

The cell lysis and fractionation market size has shown significant expansion in recent years. This market is expected to increase from $3.69 billion in 2025 to $3.95 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.0%. Historically, this growth has been driven by factors such as escalating molecular biology research activity, the expansion of proteomics studies, an increase in the application of nucleic acid purification techniques, the growth of life science laboratories, and a greater demand for standardized sample preparation methods.

The cell lysis and fractionation market size is projected to experience robust expansion over the coming years, reaching $5.16 billion by 2030, driven by a compound annual growth rate (CAGR) of 6.9%. This anticipated growth stems from factors such as increased investments in proteomics and genomics research, a growing embrace of automated sample preparation, a heightened emphasis on high-throughput analysis, the expansion of biopharmaceutical research pipelines, and the rising deployment of integrated laboratory systems. Key trends foreseen during this period encompass the wider adoption of automated cell lysis systems, a surging demand for highly efficient protein extraction, an increased application of chemical and mechanical lysis techniques, the broadening scope of fractionation-based sample preparation, and an intensified focus on maintaining sample integrity.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14064&type=smp

Which Economic Or Industry Drivers Are Impacting The Cell Lysis And Fractionation Market?

The increasing emphasis on personalized medicine is anticipated to stimulate growth in the cell lysis and fractionation markets in the coming period. Personalized medicine represents a nascent medical approach that utilizes an individual’s genetic profile to diagnose and treat illnesses, customizing medical choices and therapies according to each patient’s distinct genetic composition. Cell lysis and fractionation are fundamental to precision medicine, enabling the isolation and examination of specific subcellular components, such as proteins, organelles, and nucleic acids, from patient samples. This capability empowers scientists and medical practitioners to investigate the molecular mechanisms of disease and formulate bespoke treatments tailored to each patient’s unique molecular characteristics. As an illustration, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit, reported that in 2023, the Food and Drug Administration (FDA) approved 7 new personalized treatments for cancer, from a total of 26 personalized treatments, which was a notable rise from the 12 approved in 2022. Consequently, the expanding focus on personalized medicine is propelling the development of the cell lysis and fractionation markets.

How Are The Various Segments Of The Cell Lysis And Fractionation Market Categorized?

The cell lysis and fractionation market covered in this report is segmented –

1) By Type: Mammalian Cells, Microbial Cells

2) By Application: Nucleic Acid Purification And Isolation, Protein Purification And Isolation

3) By End-User: Research Laboratories And Institutes, Biopharmaceutical, Biotechnology Companies

Subsegments:

1) By Mammalian Cells: Adherent Mammalian Cells, Suspension Mammalian Cells, Primary Cells, Cell Lines

2) By Microbial Cells: Bacterial Cells, Yeast Cells, Fungal Cells, Algal Cells

Which Trends Are Impacting The Growth Of The Cell Lysis And Fractionation Market?

Leading firms within the cell lysis and fractionation market are concentrating on introducing sophisticated solutions, including CGT (cell and gene therapy) viral vector lysis kits, to secure a competitive advantage. These kits provide an easier AAV (Adeno-associated virus) lysis approach designed to enhance SOPs (Standard Operating Procedures), quality control, and safety, concurrently standardizing bioprocessing workflows. As an illustration, in July 2023, QIAGEN, a Germany-based company specializing in sample and assay technologies, unveiled its new CGT Viral Vector Lysis Kit, enabling the quantification of virus titers for various serotypes through a precise and consistent method beginning with cell lysates. This new CGT viral vector lysis kit augments QIAGEN’s quickly growing digital PCR product line for the biopharma sector, which currently features three QIAcuity Residual DNA Quantification Kits for assessing host cell DNA carryover and ten QIAcuity Cell and Gene Therapy (CGT) dPCR Assays used in adeno-associated virus (AAV) titer quantification.

Which Major Firms Influence Developments In The Cell Lysis And Fractionation Market?

Major companies operating in the cell lysis and fractionation market are Hoffmann-La Roche Ltd, Merck & Co. Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Lonza Group AG, Illumina Inc., Beckman Coulter Inc., PerkinElmer Inc., IDEX Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Eppendorf AG, Miltenyi Biotec B.V. & Co. KG, Promega Corporation, Takara Bio Inc., Abcam plc, Cell Signaling Technology Inc., BioVision Inc., Diagenode LLC, Claremont BioSolutions LLC, Norgen Biotek Corp., Qsonica LLC, Labfreez Instruments Group Co. Ltd.

Read the full cell lysis and fractionation market report here:

https://www.thebusinessresearchcompany.com/report/cell-lysis-and-fractionation-global-market-report

What Are The Top-Performing Regions Within The Cell Lysis And Fractionation Market?

North America was the largest region in the cell lysis and fractionation market in 2025. The regions covered in the cell lysis and fractionation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cell Lysis And Fractionation Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=14064&type=smp

Browse Through More Reports Similar to the Global Cell Lysis And Fractionation Market 2026, By The Business Research Company

Cell Separation Technologies Global Market Report

https://www.thebusinessresearchcompany.com/report/cell-separation-technologies-global-market-report

Cell Therapy Technologies Global Market Report

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

Cell Harvesting Global Market Report

https://www.thebusinessresearchcompany.com/report/cell-harvesting-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Cell Lysis And Fractionation Market During 2026–2030?

The cell lysis and fractionation market size has shown significant expansion in recent years. This market is expected to increase from $3.69 billion in 2025 to $3.95 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.0%. Historically, this growth has been driven by factors such as escalating molecular biology research activity, the expansion of proteomics studies, an increase in the application of nucleic acid purification techniques, the growth of life science laboratories, and a greater demand for standardized sample preparation methods.

The cell lysis and fractionation market size is projected to experience robust expansion over the coming years, reaching $5.16 billion by 2030, driven by a compound annual growth rate (CAGR) of 6.9%. This anticipated growth stems from factors such as increased investments in proteomics and genomics research, a growing embrace of automated sample preparation, a heightened emphasis on high-throughput analysis, the expansion of biopharmaceutical research pipelines, and the rising deployment of integrated laboratory systems. Key trends foreseen during this period encompass the wider adoption of automated cell lysis systems, a surging demand for highly efficient protein extraction, an increased application of chemical and mechanical lysis techniques, the broadening scope of fractionation-based sample preparation, and an intensified focus on maintaining sample integrity.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14064&type=smp

Which Economic Or Industry Drivers Are Impacting The Cell Lysis And Fractionation Market?

The increasing emphasis on personalized medicine is anticipated to stimulate growth in the cell lysis and fractionation markets in the coming period. Personalized medicine represents a nascent medical approach that utilizes an individual’s genetic profile to diagnose and treat illnesses, customizing medical choices and therapies according to each patient’s distinct genetic composition. Cell lysis and fractionation are fundamental to precision medicine, enabling the isolation and examination of specific subcellular components, such as proteins, organelles, and nucleic acids, from patient samples. This capability empowers scientists and medical practitioners to investigate the molecular mechanisms of disease and formulate bespoke treatments tailored to each patient’s unique molecular characteristics. As an illustration, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit, reported that in 2023, the Food and Drug Administration (FDA) approved 7 new personalized treatments for cancer, from a total of 26 personalized treatments, which was a notable rise from the 12 approved in 2022. Consequently, the expanding focus on personalized medicine is propelling the development of the cell lysis and fractionation markets.

How Are The Various Segments Of The Cell Lysis And Fractionation Market Categorized?

The cell lysis and fractionation market covered in this report is segmented –

1) By Type: Mammalian Cells, Microbial Cells

2) By Application: Nucleic Acid Purification And Isolation, Protein Purification And Isolation

3) By End-User: Research Laboratories And Institutes, Biopharmaceutical, Biotechnology Companies

Subsegments:

1) By Mammalian Cells: Adherent Mammalian Cells, Suspension Mammalian Cells, Primary Cells, Cell Lines

2) By Microbial Cells: Bacterial Cells, Yeast Cells, Fungal Cells, Algal Cells

Which Trends Are Impacting The Growth Of The Cell Lysis And Fractionation Market?

Leading firms within the cell lysis and fractionation market are concentrating on introducing sophisticated solutions, including CGT (cell and gene therapy) viral vector lysis kits, to secure a competitive advantage. These kits provide an easier AAV (Adeno-associated virus) lysis approach designed to enhance SOPs (Standard Operating Procedures), quality control, and safety, concurrently standardizing bioprocessing workflows. As an illustration, in July 2023, QIAGEN, a Germany-based company specializing in sample and assay technologies, unveiled its new CGT Viral Vector Lysis Kit, enabling the quantification of virus titers for various serotypes through a precise and consistent method beginning with cell lysates. This new CGT viral vector lysis kit augments QIAGEN’s quickly growing digital PCR product line for the biopharma sector, which currently features three QIAcuity Residual DNA Quantification Kits for assessing host cell DNA carryover and ten QIAcuity Cell and Gene Therapy (CGT) dPCR Assays used in adeno-associated virus (AAV) titer quantification.

Which Major Firms Influence Developments In The Cell Lysis And Fractionation Market?

Major companies operating in the cell lysis and fractionation market are Hoffmann-La Roche Ltd, Merck & Co. Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Lonza Group AG, Illumina Inc., Beckman Coulter Inc., PerkinElmer Inc., IDEX Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Eppendorf AG, Miltenyi Biotec B.V. & Co. KG, Promega Corporation, Takara Bio Inc., Abcam plc, Cell Signaling Technology Inc., BioVision Inc., Diagenode LLC, Claremont BioSolutions LLC, Norgen Biotek Corp., Qsonica LLC, Labfreez Instruments Group Co. Ltd.

Read the full cell lysis and fractionation market report here:

https://www.thebusinessresearchcompany.com/report/cell-lysis-and-fractionation-global-market-report

What Are The Top-Performing Regions Within The Cell Lysis And Fractionation Market?

North America was the largest region in the cell lysis and fractionation market in 2025. The regions covered in the cell lysis and fractionation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cell Lysis And Fractionation Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=14064&type=smp

Browse Through More Reports Similar to the Global Cell Lysis And Fractionation Market 2026, By The Business Research Company

Cell Separation Technologies Global Market Report

https://www.thebusinessresearchcompany.com/report/cell-separation-technologies-global-market-report

Cell Therapy Technologies Global Market Report

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

Cell Harvesting Global Market Report

https://www.thebusinessresearchcompany.com/report/cell-harvesting-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Cell Lysis And Fractionation Market During 2026–2030?

The cell lysis and fractionation market size has shown significant expansion in recent years. This market is expected to increase from $3.69 billion in 2025 to $3.95 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.0%. Historically, this growth has been driven by factors such as escalating molecular biology research activity, the expansion of proteomics studies, an increase in the application of nucleic acid purification techniques, the growth of life science laboratories, and a greater demand for standardized sample preparation methods.

The cell lysis and fractionation market size is projected to experience robust expansion over the coming years, reaching $5.16 billion by 2030, driven by a compound annual growth rate (CAGR) of 6.9%. This anticipated growth stems from factors such as increased investments in proteomics and genomics research, a growing embrace of automated sample preparation, a heightened emphasis on high-throughput analysis, the expansion of biopharmaceutical research pipelines, and the rising deployment of integrated laboratory systems. Key trends foreseen during this period encompass the wider adoption of automated cell lysis systems, a surging demand for highly efficient protein extraction, an increased application of chemical and mechanical lysis techniques, the broadening scope of fractionation-based sample preparation, and an intensified focus on maintaining sample integrity.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14064&type=smp

Which Economic Or Industry Drivers Are Impacting The Cell Lysis And Fractionation Market?

The increasing emphasis on personalized medicine is anticipated to stimulate growth in the cell lysis and fractionation markets in the coming period. Personalized medicine represents a nascent medical approach that utilizes an individual’s genetic profile to diagnose and treat illnesses, customizing medical choices and therapies according to each patient’s distinct genetic composition. Cell lysis and fractionation are fundamental to precision medicine, enabling the isolation and examination of specific subcellular components, such as proteins, organelles, and nucleic acids, from patient samples. This capability empowers scientists and medical practitioners to investigate the molecular mechanisms of disease and formulate bespoke treatments tailored to each patient’s unique molecular characteristics. As an illustration, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit, reported that in 2023, the Food and Drug Administration (FDA) approved 7 new personalized treatments for cancer, from a total of 26 personalized treatments, which was a notable rise from the 12 approved in 2022. Consequently, the expanding focus on personalized medicine is propelling the development of the cell lysis and fractionation markets.

How Are The Various Segments Of The Cell Lysis And Fractionation Market Categorized?

The cell lysis and fractionation market covered in this report is segmented –

1) By Type: Mammalian Cells, Microbial Cells

2) By Application: Nucleic Acid Purification And Isolation, Protein Purification And Isolation

3) By End-User: Research Laboratories And Institutes, Biopharmaceutical, Biotechnology Companies

Subsegments:

1) By Mammalian Cells: Adherent Mammalian Cells, Suspension Mammalian Cells, Primary Cells, Cell Lines

2) By Microbial Cells: Bacterial Cells, Yeast Cells, Fungal Cells, Algal Cells

Which Trends Are Impacting The Growth Of The Cell Lysis And Fractionation Market?

Leading firms within the cell lysis and fractionation market are concentrating on introducing sophisticated solutions, including CGT (cell and gene therapy) viral vector lysis kits, to secure a competitive advantage. These kits provide an easier AAV (Adeno-associated virus) lysis approach designed to enhance SOPs (Standard Operating Procedures), quality control, and safety, concurrently standardizing bioprocessing workflows. As an illustration, in July 2023, QIAGEN, a Germany-based company specializing in sample and assay technologies, unveiled its new CGT Viral Vector Lysis Kit, enabling the quantification of virus titers for various serotypes through a precise and consistent method beginning with cell lysates. This new CGT viral vector lysis kit augments QIAGEN’s quickly growing digital PCR product line for the biopharma sector, which currently features three QIAcuity Residual DNA Quantification Kits for assessing host cell DNA carryover and ten QIAcuity Cell and Gene Therapy (CGT) dPCR Assays used in adeno-associated virus (AAV) titer quantification.

Which Major Firms Influence Developments In The Cell Lysis And Fractionation Market?

Major companies operating in the cell lysis and fractionation market are Hoffmann-La Roche Ltd, Merck & Co. Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, Lonza Group AG, Illumina Inc., Beckman Coulter Inc., PerkinElmer Inc., IDEX Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Eppendorf AG, Miltenyi Biotec B.V. & Co. KG, Promega Corporation, Takara Bio Inc., Abcam plc, Cell Signaling Technology Inc., BioVision Inc., Diagenode LLC, Claremont BioSolutions LLC, Norgen Biotek Corp., Qsonica LLC, Labfreez Instruments Group Co. Ltd.

Read the full cell lysis and fractionation market report here:

https://www.thebusinessresearchcompany.com/report/cell-lysis-and-fractionation-global-market-report

What Are The Top-Performing Regions Within The Cell Lysis And Fractionation Market?

North America was the largest region in the cell lysis and fractionation market in 2025. The regions covered in the cell lysis and fractionation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cell Lysis And Fractionation Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=14064&type=smp

Browse Through More Reports Similar to the Global Cell Lysis And Fractionation Market 2026, By The Business Research Company

Cell Separation Technologies Global Market Report

https://www.thebusinessresearchcompany.com/report/cell-separation-technologies-global-market-report

Cell Therapy Technologies Global Market Report

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

Cell Harvesting Global Market Report

https://www.thebusinessresearchcompany.com/report/cell-harvesting-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model